Published in Br J Cancer on December 01, 1995
Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics (2010) 2.14
Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev (2014) 1.28
Kaempferol-3-O-rhamnoside isolated from the leaves of Schima wallichii Korth. inhibits MCF-7 breast cancer cell proliferation through activation of the caspase cascade pathway. Oncol Lett (2012) 1.17
Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res (2009) 1.15
Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Semin Cancer Biol (2007) 1.15
Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2. World J Gastroenterol (2006) 1.04
Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. Nutr Rev (2013) 0.95
A Dihydroxy-pentamethoxyflavone from Gardenia obtusifolia suppresses proliferation and promotes apoptosis of tumor cells through modulation of multiple cell signaling pathways. Anticancer Res (2010) 0.81
Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis. PLoS One (2016) 0.79
Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives? Nutrients (2016) 0.76
Tangeretin and its metabolite 4'-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K. Br J Pharmacol (2011) 0.75
Characterization of major metabolites of polymethoxylated flavonoids in Pericarpium Citri Reticulatae using liver microsomes immobilized on magnetic nanoparticles coupled with UPLC/MS-MS. Chem Cent J (2017) 0.75
Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo. Cancer Biol Ther (2016) 0.75
Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids. Curr Genomics (2017) 0.75
Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (1977) 12.57
Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem (1987) 10.61
Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol (1984) 6.82
Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43
Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci U S A (1983) 4.81
Apoptosis induced by anticancer drugs. Cancer Metastasis Rev (1992) 3.07
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol (1990) 2.60
The biochemistry of cell death by apoptosis. Biochem Cell Biol (1990) 2.32
A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev (1992) 2.32
Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A (1993) 2.09
Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer (1991) 2.01
The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res (1993) 1.88
Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett (1987) 1.62
Second cytotoxic pathway of diphtheria toxin suggested by nuclease activity. Science (1989) 1.60
Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res (1993) 1.56
The biology of cell death in tumours. Anticancer Res (1985) 1.51
Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res (1994) 1.41
Genistein arrests cell cycle progression at G2-M. Cancer Res (1993) 1.35
Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci (1994) 1.33
Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer (1989) 1.32
The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J Biol Chem (1992) 1.32
Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate. Biochem Biophys Res Commun (1987) 1.31
Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res (1988) 1.22
Inhibition of (Na+, K+)adenosine triphosphatase and its partial reactions by quercetin. Biochemistry (1976) 1.19
Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem (1992) 1.13
Cell-specific regulation of apoptosis by designed enediynes. Proc Natl Acad Sci U S A (1993) 1.08
Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood (1993) 1.08
The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res (1975) 1.05
Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res (1992) 1.02
Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet (1982) 1.00
Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol (1989) 0.94
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo. Cancer Res (1988) 0.89
Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells. Cancer Res (1992) 0.87
Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the "fiber hypothesis". Gastroenterology (1984) 0.86
Retinoic acid-induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human leukemia cells in primary culture: a model for differentiation inducing therapy of leukemia. Eur J Haematol (1987) 0.86
Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells. Cancer Res (1993) 0.85
Effects of synthetic and naturally occurring flavonoids on mitogen-induced proliferation of human peripheral-blood lymphocytes. Life Sci (1989) 0.84
Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells. Biochem Pharmacol (1991) 0.84
Simultaneous analysis of DNA replication and apoptosis during treatment of HL-60 cells with camptothecin and hyperthermia and mitogen stimulation of human lymphocytes. Cancer Res (1994) 0.84
UV light and ionizing radiations cause programmed death of rat chloroleukaemia cells by inducing retropositions of a mobile DNA element (L1Rn). Int J Radiat Biol (1990) 0.82
Altered expression of cell cycle related genes including c-myb in a subclone of HL-60 that exhibits reversible differentiation. Cell Growth Differ (1992) 0.80
Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1. Cancer Invest (1990) 0.78
Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones. J Nat Prod (1979) 0.78
Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol (2001) 5.42
Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev Growth Differ (1999) 3.56
An improved method for isolation of mouse pancreatic islets. Transplantation (1985) 3.52
A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev Biol (1999) 3.11
Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res (1992) 2.89
Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis (1977) 2.80
Normal and abnormal regulation of beta-msh in man. J Clin Invest (1969) 2.68
Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol (1998) 2.62
Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45
Radioimmunoassay of beta-MSH in human plasma and tissues. J Clin Invest (1967) 2.44
Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol (2001) 2.42
Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis (2001) 2.30
Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol (1998) 2.25
Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A (2001) 2.20
Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol (1990) 2.18
Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res (1969) 2.16
Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation (1987) 2.14
Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.00
Pvu-II RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Res (1988) 1.99
Quasiperiodicity and chaos in cardiac fibrillation. J Clin Invest (1997) 1.99
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer (2003) 1.95
Morphological change in the early stages of the mating process of Rhodosporidium toruloides. J Bacteriol (1975) 1.93
Accuracy and performance of the Terumo ES-H51, a new portable blood pressure monitor. Am J Hypertens (1994) 1.92
Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke (1997) 1.91
Molecular cloning of cDNA and chromosomal assignment of the gene for human phenylethanolamine N-methyltransferase, the enzyme for epinephrine biosynthesis. J Biol Chem (1988) 1.85
Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery (1992) 1.84
The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis (1993) 1.77
A cDNA clone closely associated with non-A, non-B hepatitis. Nucleic Acids Res (1990) 1.76
Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int (1993) 1.72
Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol (1997) 1.71
Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol (1984) 1.70
Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol (2007) 1.67
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Identification of the duplicated segments in rice chromosomes 1 and 5 by linkage analysis of cDNA markers of known functions. Theor Appl Genet (1994) 1.63
Mechanisms and mediators of psychological stress-induced rise in core temperature. Psychosom Med (2001) 1.62
Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab (1998) 1.62
Participation of macrophages in segmental endocapillary proliferation preceding focal glomerular sclerosis. J Pathol (1993) 1.60
Prolonged survival of hamster-to-rat liver xenografts using splenectomy and cyclosporine administration. Transplantation (1987) 1.59
Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci (2000) 1.59
Ulcerative duodenitis accompanying ulcerative colitis. J Clin Gastroenterol (2001) 1.58
The paternal methylation imprint of the mouse H19 locus is acquired in the gonocyte stage during foetal testis development. Genes Cells (2000) 1.56
Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol (1994) 1.55
Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart (2005) 1.55
Intraglomerular C3 synthesis in human kidney detected by in situ hybridization. J Am Soc Nephrol (1996) 1.54
The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Clin Endocrinol (Oxf) (1997) 1.54
Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage. Biochem Biophys Res Commun (1997) 1.53
Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies. Exp Cell Res (1996) 1.52
Delayed and selective motor neuron death after transient spinal cord ischemia: a role of apoptosis? J Thorac Cardiovasc Surg (1998) 1.52
Gastrointestinal stromal tumors of the small intestine that expressed c-kit protein. Intern Med (2000) 1.49
Histopathology of the brain vascular network in moyamoya disease. Stroke (1983) 1.49
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci U S A (1994) 1.49
Radiation therapy alone for adenocarcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys (1995) 1.48
Distinguishing beta 2-glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20. Br J Haematol (1993) 1.48
Producing a full-scale model from computed tomographic data with the rapid prototyping technique using the binder jet method: a comparison with the laser lithography method using a dry skull. J Craniofac Surg (2000) 1.48
Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasonography. J Urol (1990) 1.47
DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis (1989) 1.47
Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer (1995) 1.47
Two Japanese CADASIL families with a R141C mutation in the Notch3 gene. Intern Med (2001) 1.46
The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism (2000) 1.45
Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid. Br J Psychiatry (1994) 1.45
Salivary bisphenol-A levels detected by ELISA after restoration with composite resin. J Mater Sci Mater Med (2005) 1.45
IP(3) receptor type 3 and PLCbeta2 are co-expressed with taste receptors T1R and T2R in rat taste bud cells. Chem Senses (2001) 1.44
Bladder dysfunction due to human T-lymphotrophic virus type I associated myelopathy. Br J Urol (1991) 1.44
Benign renal tumors detected among healthy adults by abdominal ultrasonography. Eur Urol (1995) 1.43
Cautions after liver transplantation for familial amyloidotic polyneuropathy. Intern Med (2001) 1.43
Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun (2000) 1.43
Improvement of SSPE by intrathecal infusion of alpha-IFN. Neurology (2004) 1.40
Establishment of a local cooling model against spinal cord ischemia representing prolonged induction of heat shock protein. J Thorac Cardiovasc Surg (2001) 1.40
Low plasma factor XII activity in patients with systemic lupus erythematosus and a lupus anticoagulant. Blood Coagul Fibrinolysis (1997) 1.40
Myositis as a manifestation of chronic graft-versus-host disease. Intern Med (2000) 1.40
Molecular cloning and sequence of a cDNA coding for bovine lipoprotein lipase. Proc Natl Acad Sci U S A (1987) 1.39
Neither adrenergic nor cholinergic antagonists in the central nervous system affect 2-deoxy-D-glucose(2-DG)-induced hyperglycemia. Brain Res (1990) 1.39
Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients. J Gastroenterol (1998) 1.39
Suppressor cells induced by donor-specific transfusion and deoxyspergualin in rat cardiac xenografts. Transplantation (1991) 1.39
Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation. Mol Cell Biol (1999) 1.38
Intravascular coagulation in autopsy cases with liver diseases. Thromb Haemost (1979) 1.38
Human infection with the pancreas fluke, Eurytrema pancreaticum. Am J Trop Med Hyg (1983) 1.37
Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration (1996) 1.37
Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens (1997) 1.34
Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res (1991) 1.34
A new class of rapidly developing mutants in Dictyostelium discoideum: implications for cyclic AMP metabolism and cell differentiation. Dev Biol (1983) 1.34
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology (2009) 1.34
Unbiased amplification of a highly complex mixture of DNA fragments by 'lone linker'-tagged PCR. Nucleic Acids Res (1990) 1.34
Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J Neurol Sci (1998) 1.33
Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci (1994) 1.33
Microsurgical anatomy of the superficial veins of the cerebrum. Neurosurgery (1985) 1.33
The long-term outcome of laparoscopic radical nephrectomy for small renal cell carcinoma. J Urol (2001) 1.33
Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus. Proc Natl Acad Sci U S A (1985) 1.32
Mild ALS in Japan associated with novel SOD mutation. Nat Genet (1993) 1.31
Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res (1989) 1.31
Determination of ubiquinone in serum and liver by high-speed liquid chromatography. J Nutr Sci Vitaminol (Tokyo) (1978) 1.31
Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells. Oncogene (1996) 1.30
Adenosine 3',5'-monophosphate (cyclic AMP) as the mediator of the actions of melanocyte stimulating hormone (MSH) and norepinephrine on the frog skin. Endocrinology (1969) 1.29
Genomic organization and expression analysis of the mouse qkI locus. Mamm Genome (1999) 1.28
Effects of leptomycin B on the cell cycle of fibroblasts and fission yeast cells. Exp Cell Res (1990) 1.27
Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int (1998) 1.26
Isolation of morphine from toad skin. Proc Natl Acad Sci U S A (1985) 1.25